Jingqin Luo
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 19
- Cancer Genomics and Diagnostics 17
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 13
- HER2/EGFR in Cancer Research 12
- Cancer Immunotherapy and Biomarkers 11
- Cancer-related Molecular Pathways 10
- Immunology top 1%
- Genetics top 1%
- Glioma Diagnosis and Treatment 24
-
- Advanced Breast Cancer Therapies 18
- Co-authors
- Brett L. KnolhoffDavid G. DeNardoYu ZhuAndrea Wang‐GillamMelissa A. MeyerTimothy M. NyweningDavid C. LinehanS. Peter Goedegebuure
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Cell (1 paper)Proceedings of the National Academy of Sciences (2 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Jingqin Luo
182 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Cancer Research 2.1k
- Oncology 3.2k
- Immunology 2.2k
- Genetics 726
- Pulmonary and Respiratory Medicine 1.4k
Countries citing papers authored by Jingqin Luo
This map shows the geographic impact of Jingqin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingqin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingqin Luo more than expected).
Fields of papers citing papers by Jingqin Luo
This network shows the impact of papers produced by Jingqin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingqin Luo. The network helps show where Jingqin Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingqin Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 12 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 62 | |
| 6 | 2022 | 19 | |
| 7 | 2022 | 34 | |
| 8 | 2018 | 11 | |
| 9 | 2015 | 77 | |
| 10 | CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Modelsbreakdown → | 2014 | 974 |
| 11 | 2013 | 41 | |
| 12 | 2012 | 119 | |
| 13 | 2012 | 17 | |
| 14 | 2011 | 33 | |
| 15 | 2011 | 39 | |
| 16 | 2011 | 48 | |
| 17 | 2009 | 60 | |
| 18 | 2009 | 174 | |
| 19 | 2009 | 227 | |
| 20 | 2008 | 1 |
About Jingqin Luo
Jingqin Luo is a scholar working on Cancer Research, Genetics and Oncology, having authored 194 papers that have together received 8.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (24 papers), Breast Cancer Treatment Studies (19 papers), Advanced Breast Cancer Therapies (18 papers), Cancer Genomics and Diagnostics (17 papers), Cancer Treatment and Pharmacology (13 papers), HER2/EGFR in Cancer Research (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Cancer-related Molecular Pathways (10 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (3.2k citations) and Immunology (2.2k citations). Jingqin Luo has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Brett L. Knolhoff, David G. DeNardo, Yu Zhu, Andrea Wang‐Gillam, Melissa A. Meyer, Timothy M. Nywening, David C. Linehan, S. Peter Goedegebuure, Brian L. West and Joshua B. Rubin. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.